newsfilter
← Latest News
Business Wire·

Vertex to Participate in Upcoming March Investor Conferences

  • Vertex Pharmaceuticals announced management participation in two upcoming investor conferences.
  • Charlie Wagner, Chief Operating & Financial Officer, & Duncan McKechnie, Chief Commercial Officer, will attend the Leerink Global Healthcare Conference fireside chat on Tuesday, March 10, 2026, at 10:00 a.m. ET.
  • Susie Lisa, Senior Vice President, Investor Relations, & Miroslava Minkova, Executive Director, Investor Relations, will attend the Barclays 28th Annual Global Healthcare Conference fireside chat on Wednesday, March 11, 2026, at 11:30 a.m. ET.
  • Vertex is a global biotechnology company headquartered in Boston with international headquarters in London.
  • The company markets approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, & acute pain.
  • Vertex is advancing clinical programs for IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, & myotonic dystrophy type 1.
  • Vertex was founded in 1989 & maintains research & commercial offices across North America, Europe, Australia, Latin America, & the Middle East.
  • The company has been named a Top Employer by Science magazine for 16 consecutive years & is recognized by Fortune as one of the 100 Best Companies to Work For.